Influence of potassium channel modulators on cognitive processes in mice

被引:43
作者
Gherardini, C [1 ]
Galeotti, N [1 ]
Bartolini, A [1 ]
机构
[1] Univ Florence, Dept Preclin & Clin Pharmacol, I-50134 Florence, Italy
关键词
potassium channel openers; potassium channel antagonists; learning and memory; minoxidil; pinacidil; cromakalim; sulphonylureas; apamin; charybdotoxin; tetraethylammonium;
D O I
10.1038/sj.bjp.0701709
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effect of i.c.v. administration of different potassium channel openers (minoxidil, pinacidil, cromakalim) and potassium channel blockers (tetraethylammonium, apamin, charybdotoxin, gliquidone, glibenclamide) on memory processes was evaluated in the mouse passive avoidance test. 2 The administration of minoxidil (10 mu g per mouse i.c.v.), pinacidil (5-25 mu g per mouse i.c.v.) and cromakalim (10-25 mu g per mouse i.c.v.) immediately after the training session produced an amnesic effect. 3 Tetraethylammonium (TEA; 1-5 mu g per mouse i.c.v.), apamin (10 ng per mouse i.c.v.), charybdotoxin (1 mu g per mouse i.c.v.), gliquidone (3 pg per mouse i.c.v.) and glibenclamide (1 mu g per mouse i.c.v.), administered 20 min before the training session, prevented the potassium channel opener-induced amnesia. 4 At the highest effective doses, none of the drugs impaired motor coordination, as revealed by the rota rod test, or modified spontaneous motility and inspection activity, as revealed by the hole board test. 5 These results suggest that the modulation of potassium channels plays an important role in the regulation of memory processes. On this basis, the potassium channel blockers could be useful in the treatment of cognitive deficits.
引用
收藏
页码:1079 / 1084
页数:6
相关论文
共 25 条
[11]   SOLUBLE BETA-AMYLOID INDUCTION OF ALZHEIMERS PHENOTYPE FOR HUMAN FIBROBLAST K+ CHANNELS [J].
ETCHEBERRIGARAY, R ;
ITO, E ;
KIM, CS ;
ALKON, DL .
SCIENCE, 1994, 264 (5156) :276-279
[12]  
FUDENBERG HH, 1984, BIOMED PHARMACOTHER, V38, P285
[13]   PRESYNAPTIC CHOLINERGIC MODULATORS AS POTENT COGNITION ENHANCERS AND ANALGESIC DRUGS .2. 2-PHENOXY-ALKANOIC, 2-(PHENYLTHIO)-ALKANOIC, AND 2-(PHENYLAMINO)ALKANOIC ACID-ESTERS [J].
GUALTIERI, F ;
BOTTALICO, C ;
CALANDRELLA, A ;
DEI, S ;
GIOVANNONI, MP ;
MEALLI, S ;
ROMANELLI, MN ;
SCAPECCHI, S ;
TEODORI, E ;
GALEOTTI, N ;
GHELARDINI, C ;
GIOTTI, A ;
BARTOLINI, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (11) :1712-1719
[14]   PHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSE [J].
HALEY, TJ ;
MCCORMICK, WG .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1957, 12 (01) :12-15
[15]  
Halliwell J. V., 1990, POTASSIUM CHANNELS S, P348
[16]   AN IMPROVED ONE-TRIAL PASSIVE AVOIDANCE LEARNING SITUATION [J].
JARVIK, ME ;
KOPP, R .
PSYCHOLOGICAL REPORTS, 1967, 21 (01) :221-&
[17]   POTASSIUM CHANNEL ACTIVATOR DRUGS - MECHANISM OF ACTION, PHARMACOLOGICAL PROPERTIES, AND THERAPEUTIC POTENTIAL [J].
LONGMAN, SD ;
HAMILTON, TC .
MEDICINAL RESEARCH REVIEWS, 1992, 12 (02) :73-148
[18]   Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat [J].
Meiri, N ;
Ghelardini, C ;
Tesco, G ;
Galeotti, N ;
Dahl, D ;
Tomsic, D ;
Cavallaro, S ;
Quattrone, A ;
Capaccioli, S ;
Bartolini, A ;
Alkon, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4430-4434
[19]   THE EFFECT OF IMPROVED GLYCEMIC CONTROL ON COGNITIVE FUNCTIONS IN THE ELDERLY PATIENT WITH DIABETES [J].
MENEILLY, GS ;
CHEUNG, E ;
TESSIER, D ;
YAKURA, C ;
TUOKKO, H .
JOURNALS OF GERONTOLOGY, 1993, 48 (04) :M117-M121
[20]   CHARYBDOTOXIN, A PROTEIN INHIBITOR OF SINGLE CA-2(+)-ACTIVATED K+ CHANNELS FROM MAMMALIAN SKELETAL-MUSCLE [J].
MILLER, C ;
MOCZYDLOWSKI, E ;
LATORRE, R ;
PHILLIPS, M .
NATURE, 1985, 313 (6000) :316-318